Cargando…
Genome-Wide Inhibition of Pro-atherogenic Gene Expression by Multi-STAT Targeting Compounds as a Novel Treatment Strategy of CVDs
Cardiovascular diseases (CVDs), including atherosclerosis, are globally the leading cause of death. Key factors contributing to onset and progression of atherosclerosis include the pro-inflammatory cytokines Interferon (IFN)α and IFNγ and the Pattern Recognition Receptor (PRR) Toll-like receptor 4 (...
Autores principales: | Plens-Galaska, Martyna, Szelag, Malgorzata, Collado, Aida, Marques, Patrice, Vallejo, Susana, Ramos-González, Mariella, Wesoly, Joanna, Sanz, María Jesus, Peiró, Concepción, Bluyssen, Hans A. R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6156247/ https://www.ncbi.nlm.nih.gov/pubmed/30283459 http://dx.doi.org/10.3389/fimmu.2018.02141 |
Ejemplares similares
-
Targeted inhibition of STATs and IRFs as a potential treatment strategy in cardiovascular disease
por: Szelag, Malgorzata, et al.
Publicado: (2016) -
SINBAD, structural, experimental and clinical characterization of STAT inhibitors and their potential applications
por: Plens-Gałąska, Martyna, et al.
Publicado: (2022) -
Identification of STAT1 and STAT3 Specific Inhibitors Using Comparative Virtual Screening and Docking Validation
por: Szelag, Malgorzata, et al.
Publicado: (2015) -
Direct Inhibition of IRF-Dependent Transcriptional Regulatory Mechanisms Associated With Disease
por: Antonczyk, Aleksandra, et al.
Publicado: (2019) -
STAT1-Dependent Signal Integration between IFNγ and TLR4 in Vascular Cells Reflect Pro-Atherogenic Responses in Human Atherosclerosis
por: Chmielewski, Stefan, et al.
Publicado: (2014)